Abdul Mullick

Directeur Général chez KYOWA KIRIN CO., LTD.

Health Technology

Consumer Services

Commercial Services

Profil

Abdul Mullick is President, CEO, COO & Representative Director at Kyowa Kirin Co., Ltd. since 2026 and Director at Orchard Therapeutics Plc since 2024.
Former roles include President & Chief Executive Officer at Kyowa Kirin International Plc from 2018 to 2023, Director at Mereo BioPharma Group Plc in 2022, Head-Global Strategic Marketing at Vifor Pharma Management AG from 2014 to 2018, Senior Director-European Business Unit at Endocrine Pharmaceuticals Ltd., Senior Director-Global Brand & Diabetes at Novartis Pharma AG, Vice President, GM-Endocrinology & Cardiology at Genzyme Corp.
Education includes a doctorate from the University of Bristol.

Postes actifs de Abdul Mullick

Sociétés	Poste	Début
ORCHARD THERAPEUTICS PLC	Directeur/Membre du Conseil	24/01/2024
KYOWA KIRIN CO., LTD.	Directeur Général	01/03/2026

Tous les postes actifs de Abdul Mullick

Anciens postes connus de Abdul Mullick

Sociétés	Poste	Fin
Kyowa Kirin International Plc Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes antibodies, cell & gene therapies for hematological, bone, mineral, haemato-oncology and rare diseases	Directeur Général	01/01/2023
MEREO BIOPHARMA GROUP PLC	Directeur/Membre du Conseil	10/11/2022
Vifor Pharma Management AG Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency	Corporate Officer/Principal	01/04/2018
Endocrine Pharmaceuticals Ltd. Endocrine Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Develops hormonal drugs	Corporate Officer/Principal	-
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Corporate Officer/Principal	-

Voir l'expérience en détail de Abdul Mullick

Formation de Abdul Mullick

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Abdul Mullick

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	9
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Health Technology
Kyowa Kirin International Plc Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes antibodies, cell & gene therapies for hematological, bone, mineral, haemato-oncology and rare diseases	Health Technology
University of Bristol University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Endocrine Pharmaceuticals Ltd. Endocrine Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Develops hormonal drugs	Commercial Services
Kyowa Kirin Co., Ltd. Kyowa Kirin Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals; develops biochemical reagents and other chemicals	Health Technology
Novartis Pharma AG Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company	Health Technology
Vifor Pharma Management AG Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency	Health Technology
Mereo BioPharma Group Plc Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company	Health Technology
Orchard Therapeutics Plc Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases	Health Technology